Key words: bronchodilation; diffusing capacity; high-resolution CT; lung volumes; spirometry
|
|
- Marian Byrd
- 6 years ago
- Views:
Transcription
1 Assessment of Emphysema in COPD* A Functional and Radiologic Study Isa Cerveri, MD; Roberto Dore, MD; Angelo Corsico, MD, PhD; Maria C. Zoia, MD; Riccardo Pellegrino, MD; Vito Brusasco, MD; and Ernesto Pozzi, MD Objectives: A combination of functional measurements reflecting a decrease in maximum flow, a degree of lung hyperinflation, the relationship between maximum inspiratory and expiratory flows, bronchodilator response, and diffusing capacity of the lung for carbon monoxide (DLCO) was used to quantify the extent of emphysema, as assessed by high-resolution CT (HRCT) scanning. Design: Forced inspiratory and expiratory spirometry, lung volumes, reversibility test, and singlebreath diffusing capacity were assessed before and after inhaling albuterol, 200 g. Relationships between lung function variables and emphysema extent, as determined by HRCT scanning, were tested by univariate and multivariate analyses. Subjects: Thirty-nine COPD outpatients with moderate-to-severe obstruction. Measurements and results: Emphysema extent, as assessed by HRCT scanning, ranged from 18 to 70%. All of the lung function parameters that were studied, except for the change in FEV 1 percent predicted after salbutamol inhalation, correlated significantly with the extent of emphysema (r 2 range, 0.19 to 0.44). Functional residual capacity, forced expiratory flow at 50% of FVC/forced inspiratory flow at 50% of FVC, DLCO/alveolar volume ratio, and bronchodilator-induced change in FEV 1 /FVC ratio were the only variables retained by stepwise multiple regression analysis. The multiple regression model explained 71% of the variability of emphysema extent measured by HRCT scanning. Conclusions: The combination of lung function measurements reflecting lung hyperinflation, bronchial collapsibility, lung diffusing capacity, and bronchodilator response provides a good estimate of the extent of emphysema, as evaluated by HRCT scanning. These data suggest that pulmonary function tests are useful in assessing and monitoring parenchymal damage in COPD patients. (CHEST 2004; 125: ) Key words: bronchodilation; diffusing capacity; high-resolution CT; lung volumes; spirometry Abbreviations: Dlco diffusing capacity of the lung for carbon monoxide; FEF 50 forced expiratory flow at 50% of FVC; FIF 50 forced inspiratory flow at 50% of FVC; FRC functional residual capacity; HRCT high-resolution CT; RV residual volume; TGV thoracic gas volume; TLC total lung capacity; VA alveolar volume Airflow obstruction in COPD patients is believed to be largely secondary to airway damage and remodeling, while emphysema is considered to play *From the Clinica di Malattie dell Apparato Respiratorio (Drs. Cerveri, Corsico, Zoia, and Pozzi) and Istituto di Radiologia Medica (Dr. Dore), Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo, Università di Pavia, Pavia, Italy; Servizio di Fisiopatologia Respiratoria (Dr. Pellegrino), AO S. Croce e Carle, Cuneo, Italy; and Servizio di Fisiopatologia Respiratoria, Dipartimento di Medicina Interna (Dr. Brusasco), Università di Genova, Genova, Italy. This work was supported in part by a grant from Current Research Project- Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo, Pavia, Italy. Manuscript received July 16, 2003; revision accepted November 25, Reproduction of this article is prohibited without written permission from the American College of Chest Physicians ( permissions@chestnet.org). Correspondence to: Isa Cerveri, MD, Clinica di Malattie dell Apparato Respiratorio, IRCCS Policlinico S. Matteo, via Taramelli 5, Pavia, Italy; i.cerveri@libero.it only a minor role. 1 As a consequence, the pharmacologic interventions recommended for COPD patients 1 are uniquely aimed at increasing airway caliber and reducing airway inflammation. This approach is also justified by the present unavailability of drugs that are able to modify lung parenchymal properties. 2 However, it can be expected that new drugs will be developed in the future in an attempt to specifically treat airway or parenchymal damage. If this will be the case, the variability of response to treatments could be reduced by assessing patients for the presence and extent of emphysema. High-resolution CT (HRCT) scanning is considered to be a sensitive technique for detecting and quantifying pulmonary emphysema in vivo, 3 but it may not be easy to obtain in many centers and is not suitable for follow-up. Studies attempting to relate pulmonary function measurements to HRCT scan 1714 Clinical Investigations
2 findings have been disappointing, as correlations explaining no more than one fourth to one half of variability were generally found, 4 possibly because none of the parameters recommended for lung function testing in COPD patients is uniquely sensitive to the pathologic features of emphysema. Maximum expiratory flow is reduced in emphysema because of the loss of lung elastic recoil, but it also may be decreased in intrinsic airway obstruction. The diffusing capacity of the lung for carbon monoxide (Dlco) is reduced in emphysema patients because of the loss of alveolar-to-capillary surface, but it also may be decreased due to very severe airway obstruction. In addition to the reduction of maximal expiratory flow, which is generally assessed by FEV 1, other mechanical abnormalities may reflect the loss of lung elastic recoil. Among these abnormalities are lung hyperinflation, 5 airway collapsibility, 6 and altered airway-to-parenchyma interdependence. 7 9 The aim of the present study was to examine to what extent a combination of noninvasive pulmonary function measurements reflecting the above features is capable of quantifying the presence of emphysema in COPD subjects in comparison with HRCT scanning. Subjects Materials and Methods Thirty-five male subjects and 4 female subjects affected by COPD 10 took part in this study (Table 1). All subjects were smokers or past smokers; 36 subjects had a history of chronic cough and phlegm, and 20 subjects had reported dyspnea. All subjects were required to abstain from receiving short-acting bronchodilators for at least 12 h, to be in a stable clinical condition, and not to have experienced respiratory exacerbations in the previous month. The study was approved by the local ethics committee, and informed consent was obtained from all subjects. Table 1 Anthropometric and Pulmonary Function Variables Mean SD Range Age, yr Height, cm FEV 1, % predicted FVC, % predicted FEF 50, L/s FIF 50, L/s FRC, % predicted RV, % predicted TLC, % predicted FEV 1 change,* % predicted FEV 1 /FVC change,* % Dlco, % predicted Dlco/VA *After salbutamol administration. Pulmonary Function On the first day of the study, a complete lung function test was obtained before and 30 min after inhalation of 200 g of salbutamol (Autobox V6200 and V max 22 system; SensorMedics Corporation; Yorba Linda, CA). At baseline and after salbutamol administration, FVC and FEV 1 were measured according to the American Thoracic Society guidelines. 11 The change in FEV 1 after salbutamol administration (expressed as percentage of predicted values) was taken as the traditional index of bronchodilation. As it is well-known, 7 9 a large proportion of patients with emphysema show an increase in FVC despite minimal or no change in FEV 1. This indisputable sign of bronchodilation is called isolated volume response. Thus, the change in the FEV 1 /FVC ratio after salbutamol therapy (ie, post-fev 1 /FVC % pre-fev 1 /FVC %) was taken as an index of relative response in terms of flow and volume. Forced expiratory flow measured at 50% of FVC (FEF 50 ) and forced inspiratory flow measured at 50% of FVC (FIF 50 ) were taken on the flow-volume loops showing the best combination of FVC and FEV 1, and superimposable inspiratory flows. The FEF 50 /FIF 50 ratio was taken as an index of airway collapsibility. Thoracic gas volume (TGV) was measured by body plethysmography, with the subjects panting against a closed shutter at a frequency slightly 1 Hz and their cheeks supported by their hands. Total lung capacity (TLC) was obtained as the sum of TGV and linked inspiratory capacity. Residual volume (RV) was the difference between TLC and a relaxed vital capacity. Functional residual capacity (FRC) was obtained from TGV values that were corrected for any difference between the volume at which the shutter was closed and the average end-expiratory volume of the four preceding regular tidal breaths. Predicted values for spirometry and lung volumes are from Quanjer et al. 12 Dlco and alveolar volume (VA) were measured at least in duplicate, as described by Huang and MacIntyre. 13 Predicted values are derived from Cotes et al. 14 HRCT Imaging A third-generation, continuous-rotation CT scanner with volume acquisition extendable to 24 s (Somaton Plus; Siemens; Erlangen, Germany) was used. The quantitative evaluation of emphysema was based on three scans of 2-mm thick sections that were acquired with 200-mA tube current, and were obtained at the levels of the aortic arch, tracheal carina, and pulmonary veins while the patient was holding his breath at RV. By using appropriate software (Siemens) and the density mask method, 15 the percentage of pixels with a density of 900 Hounsfield units at full expiration was calculated. 3,16 Statistical Analysis The normality of the data distribution was assessed by the Shapiro-Wilks test. Relationships between variables were tested by linear regression analysis and Pearson correlation coefficient. The simultaneous effects of lung function parameters were analyzed by multiple linear regression analysis, with emphysema extent determined by HRCT scan as the dependent variable and independent variables selected by a stepwise procedure. The independent variables were FEV 1 (percentage of predicted), FRC (percentage of predicted), TLC (percentage of predicted), RV (percentage of predicted), RV/TLC ratio, Dlco (percentage of predicted), Dlco/VA ratio, FEF 50 /FIF 50 ratio, salbutamol-induced change in FEV 1 (percent predicted), and salbutamol-induced change in FEV 1 / FVC ratio. Values of p 0.05 were considered to be statistically significant. All tests were two-sided using a statistical software package (Statistica for Windows, version 6; StatSoft; Tulsa, OK). Data are presented as the mean SD. CHEST / 125 / 5/ MAY,
3 Results All subjects had moderate-to-severe airflow obstruction (Table 1), and most of them also had lung hyperinflation (ie, and increase in FRC), gas trapping (ie, an increase in RV), and reduction of Dlco. In all subjects, FEF 50 values were always remarkably less than the FIF 50 values, with the ratio FEF 50 /FIF 50 ratio ranging from 0.1 to 0.4. The salbutamol-induced change in FEV 1 ranged from 1 to 26% predicted, and the absolute change in FEV 1 /FVC ratio ranged from 11 to 12%. The mean extent of emphysema determined by HRCT scan was 39 12% (range, 18 to 70%) of the total lung cross-sectional area, and was correlated with FEV 1, FRC, TLC, RV, and Dlco, with the ratios RV/TLC, FEF 50 /FIF 50, and Dlco/VA, and with FEV 1 /FVC ratio (Table 2). The relationships of lung function parameters with each other are reported in Table 3. The variance of emphysema extent measured by HRCT scan that was explained by each single lung function parameter ranged from 19 to 44%. A much greater proportion of emphysema extent measured by HRCT scanning was explained by the following multiple regression model with four independent variables selected by a stepwise procedure: emphysema extent (%) FRC 0.30 FEF 50 /FIF Dlco/VA 0.26 FEV i /FVC (r , p 0.001) The relationship between the model estimate and emphysema extent measured by HRCT scan is presented in Figure 1. Discussion The main finding of this study was that a fairly large proportion of the emphysema assessed by Table 2 Relationship Between Functional Variables and Emphysema Extent as Assessed by HRCT Scan* Variables r Value p Value FEV 1, % predicted FRC, % predicted RV, % predicted TLC, % predicted RV/TLC ratio Dlco, % predicted Dlco/VA ratio FEF 50 /FIF 50 ratio, L/s FEV 1 change, % predicted 0.29 NS FEV 1 /FVC ratio change, % *NS not significant. After salbutamol administration. HRCT scan was explained by a multiple regression model, including noninvasive lung function measurements reflecting lung hyperinflation, bronchial collapsibility, alveolar-to-capillary diffusion capacity, and bronchodilator response. It is well-recognized that COPD is a very inhomogeneous condition, and this is likely the major reason for the inconsistency of the results among clinical trials. It is conceivable that a better characterization of the underlying disease may help to reduce the variability of response to therapeutic interventions in COPD patients. However, the recently published guidelines of the Global Initiative for Chronic Obstructive Lung Disease 1 consider COPD patients as a homogeneous population, at least with regard to pharmacologic treatment. Accordingly, only simple spirometry is recommended to evaluate the presence and severity of airway obstruction, while the assessment of emphysema by HCRT scan is restricted to those patients who are possible candidates for surgery. In the last few years, great attention has been paid to drugs that specifically address either airflow obstruction (eg, phosphodiesterases inibitors) or parenchymal damage (eg, 1 -antitrypsin augmentation therapy). From this perspective, a quantification of emphysema may help to tailor treatments to individual patients. The use of HRCT scanning for the assessment of emphysema has some limitations. First, it may not be easy to obtain in a number of centers. Second, it exposes the patient to radiation. Third, it cannot be taken as an indisputable gold standard for the quantification of emphysema, as it provides correlation coefficients with lung pathology ranging from 0.7 to Fourth, it is not suitable for follow-up. However, lung function tests are easy to obtain in most centers, but the relationships between single parameters and the extent of emphysema, determined either by pathology or HRCT scan, are rather weak. 3,20 24 The present study gives an answer to the following two practical questions: whether the extent of emphysema can be assessed by lung function tests; and which measurements are useful in achieving agreement with HRCT scan data. Lung hyperinflation is well-known as a major characteristic of emphysema patients 25,26 and is regarded as reflecting the quintessential feature of this disease (ie, the decrease in lung elastic recoil). Respiratory system mechanics predict that a decrease in lung elastic recoil should result in an increase of both FRC and TLC. 5 In the present study, both TLC and FRC significantly correlated with the extent of emphysema as determined by HRCT scan, but only FRC was retained as being significant in the multiple regression model. As lung volume were significantly correlated, the retention of FRC only could have been an artifact due to the 1716 Clinical Investigations
4 Table 3 Correlation Matrix of All Variables Submitted to Stepwise Multiple Regression Analysis Variables FEV 1 FRC RV TLC RV/ TLC Dlco Dlco/VA FEF 50 /FIF 50 Ratio FEV 1 Change* FEV 1 / FVC Change* FEV 1, % predicted FRC, % predicted RV, % predicted TLC, % predicted RV/TLC ratio Dlco, % predicted Dlco/VA ratio FEF 50 /FIF 50 ratio, L/s FEV 1 change FEV 1 /FVC ratio change % *After salbutamol administration. p Figure 1. Relationship between the extent of emphysema, as measured by HRCT scan, and that estimated by the multiple regression model (see Results section). The line of identity is shown. order in which variables were entered into the stepwise selection procedure. However, when a multiple regression analysis was performed by entering lung volume measurements in all possible combinations without stepwise selection, the model shown in the Results section remained the one that best fitted the experimental data. Furthermore, when FRC was forcefully excluded from the model, TLC was retained but the r 2 was slightly decreased (from 0.71 to 0.68). Physiologically, this may appear surprising because FRC, unlike TLC, also is determined by dynamic mechanisms, such as altered breathing pattern, increase in time constant of respiratory system, and expiratory flow limitation, 27 which may be present in COPD patients without emphysema. A possible explanation for this findings is that HRCT scans were obtained at RV, which also is determined by dynamic mechanisms. 27 It cannot be excluded that using HRCT measurements taken at full inspiration might have been better correlated with TLC than FRC. However, HRCT scan measurements at full expiration correlated with physiologic variables better than those taken at full inspiration. 16,28,29 An alternative, but not exclusive, explanation is that the increase in TLC may be limited in some subjects with emphysema by a reduction of inspiratory muscle force. 30 Airflow obstruction in COPD patients is variably due to intrinsic airway obstruction or the loss of lung elastic recoil. 5 In the presence of emphysema, the caliber of intraparenchymal airways is expected to be much less on expiration than on inspiration because airway walls are more compressible or the tethering force of lung parenchyma is reduced. 6 The significant inverse relationship between the FEF 50 /FIF 50 ratio and the extent of emphysema as assessed by HRCT scan confirms these predictions. In our previous study, 9 we showed that an isolated volume response to bronchodilators occurred in patients with emphysema as a result of an increase in flow, mostly occurring at low lung volumes rather than high lung volumes. This phenomenon was found to be associated with a paradoxical decrease in small airway caliber from FRC to TLC as measured by HRCT, thus reflecting an altered coupling between airways and lung parenchyma. In the present study, the significant inverse relationship between changes in FEV 1 /FVC ratio after salbutamol administration and the extent of emphysema reflects the fact that volume responses (ie, an increase in FVC) exceeded flow responses (ie, an increase in FEV 1 ). CHEST / 125 / 5/ MAY,
5 Finally, as abundantly documented in the literature, the more extensive the emphysema, the lower the Dlco. This feature is deemed to reflect the pathologic consequences of lung hyperinflation and alveolar disruption on the vascular side. 20 Other variables that were significantly correlated with the extent of emphysema were FEV 1, RV, and RV/TLC ratio. Among the possible reasons for this are that the decrease in flow and the occurrence of airway closure at high lung volume is due either to a decrease in elastic recoil, as is the case in emphysema patients, or to intrinsic airway disease, as is the case in patients with chronic bronchitis. Although the prediction formula found in this study cannot be generalized before it is tested in subjects who are different from those from whom it was generated, the clinical implications of the present findings are that a multiple regression model based on noninvasive lung function measurements provides a good estimate of the extent of emphysema in COPD patients, as assessed by HRCT scanning. In consideration of the fact that HRCT scanning exposes the patient to radiation and cannot be used repeatedly to monitor the disease, this functional approach may be particularly useful for clinical trials of new treatments for COPD. References 1 Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: Boschetto P, Miniati M, Miotto D, et al. Predominant emphysema phenotype in chronic obstructive pulmonary. Eur Respir J 2003; 21: Madani A, Keyzer C, Gevenois PA. Quantitative computed tomography assessment of lung structure and function in pulmonary emphysema. Eur Respir J 2001; 18: Thurlbeck WM. Emphysema then and now. Can Respir J 1994; 1: Pride NB, Macklem PT. Lung mechanics in disease. In: Macklem PT, Mead J, eds. Handbook of physiology: the respiratory system; mechanics of breathing. Bethesda, MD: American Physiological Society, 1986; Stanescu D, Veriter C, Van de Woestijne KP. Maximal inspiratory flow rates in patients with COPD. Chest 2000; 118: O Donnell DE, Forkert L, Webb KA. Evaluation of bronchodilator responses in patients with irreversible emphysema. Eur Respir J 2001; 18: Newton MF, O Donnell DE, Forkert L. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest 2002; 121: Cerveri I, Pellegrino R, Dore R, et al. Mechanisms for isolated volume response to a bronchodilator in patients with COPD. J Appl Physiol 2000; 88: American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6(suppl): Huang YC, MacIntyre NR. Real-time gas analysis improves the measurement of single-breath diffusing capacity. Am Rev Respir Dis 1992; 146: Cotes JE, Chinn DJ, Quanjer PH, et al. Standardization of the measurement of transfer factor (diffusing capacity). Eur Respir J 1993; 17: Muller NL, Staples CA, Miller RR, et al. Density mask : an objective method to quantitate emphysema using computed tomography. Chest 1988; 94: Knudson RJ, Standen JR, Kaltenborn WT, et al. Expiratory computed tomography for assessment of suspected pulmonary emphysema. Chest 1991; 99: Kuwano K, Matsuba K, Ikeda T, et al. The diagnosis of mild emphysema: correlation of computed tomography and pathology scores. Am Rev Respir Dis 1990; 141: Hruban RH, Meziane MA, Zerhouni EA, et al. High resolution computed tomography of inflation-fixed lungs: pathologic-radiologic correlation of centrilobular emphysema. Am Rev Respir Dis 1987; 136: Gevenois PA, de Maertelaer V, De Vuyst P, et al. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995; 152: Park SS, Janis M, Shim CS, et al. Relationship of bronchitis and emphysema to altered pulmonary function. Am Rev Respir Dis 1970; 102: Morrison NJ, Abboud RT, Ramadan F, et al. Comparison of single breath carbon monoxide diffusing capacity and pressure-volume curves in detecting emphysema. Am Rev Respir Dis 1989; 139: Robbesom AA, Versteeg EM, Veerkamp JH, et al. Morphological quantification of emphysema in small human lung specimens: comparison of methods and relation with clinical data. Mod Pathol 2003; 16: Baldi S, Miniati M, Bellina CR, et al. Relationship between extent of pulmonary emphysema by high-resolution computed tomography and lung elastic recoil in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: Cosio MG, Snider GL. Chest computed tomography: is it ready for major studies of chronic obstructive pulmonary disease? Eur Respir J 2001; 17: Gevenois PA, Scillia P, de Maertelaer V, et al. The effects of age, sex, lung size, and hyperinflation on CT lung densitometry. AJR Am J Roentgenol 1996; 167: Kinsella M, Muller NL, Staples C, et al. Hyperinflation in asthma and emphysema: assessment by pulmonary function testing and computed tomography. Chest 1988; 94: Pellegrino R, Brusasco V. On the causes of lung hyperinflation during bronchoconstriction. Eur Respir J 1997; 10: Lamers RJ, Thelissen GR, Kessels AG, et al. Chronic obstructive pulmonary disease: evaluation with spirometrically controlled CT lung densitometry. Radiology 1994; 193: Eda S, Kubo K, Fujimoto K, et al. The relations between expiratory chest CT using helical CT and pulmonary function tests in emphysema. Am J Respir Crit Care Med 1997; 155: Bellemare F, Grassino A. Force reserve of the diaphragm in patients with chronic obstructive pulmonary disease. J Appl Physiol 1983; 55: Clinical Investigations
Difference Between The Slow Vital Capacity And Forced Vital Capacity: Predictor Of Hyperinflation In Patients With Airflow Obstruction
ISPUB.COM The Internet Journal of Pulmonary Medicine Volume 4 Number 2 Difference Between The Slow Vital Capacity And Forced Vital Capacity: Predictor Of Hyperinflation In Patients With Airflow Obstruction
More informationMaximal expiratory flow rates (MEFR) measured. Maximal Inspiratory Flow Rates in Patients With COPD*
Maximal Inspiratory Flow Rates in Patients With COPD* Dan Stănescu, MD, PhD; Claude Veriter, MA; and Karel P. Van de Woestijne, MD, PhD Objectives: To assess the relevance of maximal inspiratory flow rates
More informationPULMONARY FUNCTION TESTING. Purposes of Pulmonary Tests. General Categories of Lung Diseases. Types of PF Tests
PULMONARY FUNCTION TESTING Wyka Chapter 13 Various AARC Clinical Practice Guidelines Purposes of Pulmonary Tests Is lung disease present? If so, is it reversible? If so, what type of lung disease is present?
More informationBasic approach to PFT interpretation. Dr. Giulio Dominelli BSc, MD, FRCPC Kelowna Respiratory and Allergy Clinic
Basic approach to PFT interpretation Dr. Giulio Dominelli BSc, MD, FRCPC Kelowna Respiratory and Allergy Clinic Disclosures Received honorarium from Astra Zeneca for education presentations Tasked Asked
More informationQuantitative CT in Chronic Obstructive Pulmonary Disease: Inspiratory and Expiratory Assessment
Cardiopulmonary Imaging Original Research kira et al. CT of Chronic Obstructive Pulmonary Disease Cardiopulmonary Imaging Original Research Masanori kira 1 Kazushige Toyokawa 1 Yoshikazu Inoue 2 Toru rai
More informationWhat do pulmonary function tests tell you?
Pulmonary Function Testing Michael Wert, MD Assistant Professor Clinical Department of Internal Medicine Division of Pulmonary, Critical Care, and Sleep Medicine The Ohio State University Wexner Medical
More informationKey words: aging; bronchial obstruction; bronchoconstriction; bronchodilation; COPD; deep inspiration; methacholine
Bronchodilatory Effect of Deep Inspiration Is Absent in Subjects With Mild COPD* Nicola Scichilone, MD; Roberto Marchese, MD; Filippo Catalano, MD; Antonio Maurizio Vignola, MD; Alkis Togias, MD; and Vincenzo
More informationPFT Interpretation and Reference Values
PFT Interpretation and Reference Values September 21, 2018 Eric Wong Objectives Understand the components of PFT Interpretation of PFT Clinical Patterns How to choose Reference Values 3 Components Spirometry
More informationPulmonary Function Testing: Concepts and Clinical Applications. Potential Conflict Of Interest. Objectives. Rationale: Why Test?
Pulmonary Function Testing: Concepts and Clinical Applications David M Systrom, MD Potential Conflict Of Interest Nothing to disclose pertinent to this presentation BRIGHAM AND WOMEN S HOSPITAL Harvard
More informationC hronic obstructive pulmonary disease (COPD) develops
837 CHRONIC OBSTRUCTIVE PULMONARY DISEASE Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD R A O Donnell, C Peebles, J A Ward, A Daraker, G
More informationTeacher : Dorota Marczuk Krynicka, MD., PhD. Coll. Anatomicum, Święcicki Street no. 6, Dept. of Physiology
Title: Spirometry Teacher : Dorota Marczuk Krynicka, MD., PhD. Coll. Anatomicum, Święcicki Street no. 6, Dept. of Physiology I. Measurements of Ventilation Spirometry A. Pulmonary Volumes 1. The tidal
More informationLung Function Basics of Diagnosis of Obstructive, Restrictive and Mixed Defects
Lung Function Basics of Diagnosis of Obstructive, Restrictive and Mixed Defects Use of GOLD and ATS Criteria Connie Paladenech, RRT, RCP, FAARC Benefits and Limitations of Pulmonary Function Testing Benefits
More informationQuantitative Assessment of Air Trapping in Chronic Obstructive Pulmonary Disease Using Inspiratory and Expiratory Volumetric MDCT
Chest Imaging Original Research Matsuoka et al. MDCT of Air Trapping in COPD Chest Imaging Original Research Shin Matsuoka 12 Yasuyuki Kurihara 1 Kunihiro Yagihashi 1 Makoto Hoshino 3 Naoto Watanabe 3
More informationExpiratory and inspiratory chest computed tomography and pulmonary function tests in cigarette smokers
Eur Respir J 1999; 13: 252±256 Printed in UK ± all rights reserved Copyright ERS Journals Ltd 1999 European Respiratory Journal ISSN 0903-1936 Expiratory and inspiratory chest computed tomography and pulmonary
More informationCoexistence of confirmed obstruction in spirometry and restriction in body plethysmography, e.g.: COPD + pulmonary fibrosis
Volumes: IRV inspiratory reserve volume Vt tidal volume ERV expiratory reserve volume RV residual volume Marcin Grabicki Department of Pulmonology, Allergology and Respiratory Oncology Poznań University
More informationSpirometry. Obstruction. By Helen Grim M.S. RRT. loop will have concave appearance. Flows decreased consistent with degree of obstruction.
1 2 Spirometry By Helen Grim M.S. RRT 3 4 Obstruction loop will have concave appearance. Flows decreased consistent with degree of obstruction. Volumes may be normal, but can decrease with severity of
More informationDivision of Medicine, "Division of Rehabilitation, Misasa Medical Center, Okayama University Medical and Dental School
35 Low attenation area in asthma and Difference in low attenuation area (LAA) of the lungs on high resolution computed tomography (HRCT) between asthma and in relation to cigarette smoking Fumihiro Mitsunobu,
More informationLung elastic recoil during breathing at increased lung volume
Lung elastic recoil during breathing at increased lung volume JOSEPH R. RODARTE, 1 GASSAN NOREDIN, 1 CHARLES MILLER, 1 VITO BRUSASCO, 2 AND RICCARDO PELLEGRINO 3 (With the Technical Assistance of Todd
More informationLung elastic recoil during breathing at increased lung volume
Lung elastic recoil during breathing at increased lung volume JOSEPH R. RODARTE, 1 GASSAN NOREDIN, 1 CHARLES MILLER, 1 VITO BRUSASCO, 2 AND RICCARDO PELLEGRINO 3 (With the Technical Assistance of Todd
More informationSang Min Lee, M.D., Jin Hur, M.D., Tae Hoon Kim, M.D., Sang Jin Kim, M.D., Hyung Jung Kim, M.D. 2
Quantitative Assessment of Lung Volumes using Multidetector Row Computed Tomography (MDCT) in Patients with Chronic Obstructive Pulmonary Disease (COPD) 1 Sang Min Lee, M.D., Jin Hur, M.D., Tae Hoon Kim,
More informationPulmonary Function Testing
In the Clinic Pulmonary Function Testing Hawa Edriss MD, Gilbert Berdine MD The term PFT encompasses three different measures of lung function: spirometry, lung volumes, and diffusion capacity. In this
More information6- Lung Volumes and Pulmonary Function Tests
6- Lung Volumes and Pulmonary Function Tests s (PFTs) are noninvasive diagnostic tests that provide measurable feedback about the function of the lungs. By assessing lung volumes, capacities, rates of
More informationSmall Airways Disease. Respiratory Function In Small Airways And Asthma. Pathophysiologic Changes in the Small Airways of Asthma Patients
Small Airways Disease Respiratory Function In Small Airways And Relevant Questions On Small Airway Involvement In How can small airway disease be defined? What is the link between small airway abnormalities
More informationFVC to Slow Inspiratory Vital Capacity Ratio* A Potential Marker for Small Airways Obstruction
Original Research PSYCHOLOGICAL TESTING FVC to Slow Inspiratory Vital Capacity Ratio* A Potential Marker for Small Airways Obstruction Judith Cohen, MD; Dirkje S. Postma, MD, PhD; Karin Vink-Klooster;
More informationPulmonary Function Testing The Basics of Interpretation
Pulmonary Function Testing The Basics of Interpretation Jennifer Hale, M.D. Valley Baptist Family Practice Residency Objectives Identify the components of PFTs Describe the indications Develop a stepwise
More informationSupplementary Online Content
Supplementary Online Content Regan EA, Lynch DA, Curran-Everett D, et al; Genetic Epidemiology of COPD (COPDGene) Investigators. Clinical and radiologic disease in smokers with normal spirometry. Published
More informationParametric response mapping
Parametric response mapping Utility of a novel imaging biomarker in pulmonary disease Dharshan Vummidi MD, Lama VN MD, Yanik G MD, Kazerooni EA MD, Meilan Han MD, Galban C PhD Radiology, Pulmonary & Critical
More informationHigh resolution computed tomography (HRCT) assessment of β 2 -agonist induced bronchodilation in chronic obstructive pulmonary disease patients
European Review for Medical and Pharmacological Sciences High resolution computed tomography (HRCT) assessment of β 2 -agonist induced bronchodilation in chronic obstructive pulmonary disease patients
More informationInterpreting pulmonary function tests: Recognize the pattern, and the diagnosis will follow
REVIEW FEYROUZ AL-ASHKAR, MD Department of General Internal Medicine, The Cleveland Clinic REENA MEHRA, MD Department of Pulmonary and Critical Care Medicine, University Hospitals, Cleveland PETER J. MAZZONE,
More informationQuantitative evaluation by high resolution computed tomography (HRCT) of patients with asthma and emphysema
19 Evaluation by HRCT in asthma and emphysema Quantitative evaluation by high resolution computed tomography (HRCT) of patients with asthma and emphysema Fumihiro Mitsunobu, Takashi Mifune, Kozo Ashida,
More informationPULMONARY FUNCTION. VOLUMES AND CAPACITIES
PULMONARY FUNCTION. VOLUMES AND CAPACITIES The volume of air a person inhales (inspires) and exhales (expires) can be measured with a spirometer (spiro = breath, meter = to measure). A bell spirometer
More informationLung Pathophysiology & PFTs
Interpretation of Pulmonary Function Tests (PFTs) Course # 1612 2:00 5:00pm Friday February 22, 2013 Lung Pathophysiology & PFTs Mark F. Sands MD, FCCP, FAAAAI Division of Allergy, Immunology & Rheumatology
More informationSIMONETTA BALDI, MASSIMO MINIATI, CALOGERO RICCARDO BELLINA, LUIGI BATTOLLA, GIOSUÉ CATAPANO, ENRICO BEGLIOMINI, DAVIDE GIUSTINI, and CARLO GIUNTINI
Relationship between Extent of Pulmonary Emphysema by High-resolution Computed Tomography and Lung Elastic Recoil in Patients with Chronic Obstructive Pulmonary Disease SIMONETTA BALDI, MASSIMO MINIATI,
More informationLung mechanics in subjects showing increased residual volume without bronchial obstruction
Lung mechanics in subjects showing increased residual volume without bronchial obstruction S VULTERINI, M R BIANCO, L PELLICCIOTTI, AND A M SIDOTI From the Divisione di Medicina Generale, Ospedale Fatebenefratelli,
More informationIn patients with symptomatic COPD, desirable. Assessment of Bronchodilator Efficacy in Symptomatic COPD* Is Spirometry Useful?
Assessment of Bronchodilator Efficacy in Symptomatic COPD* Is Spirometry Useful? Denis E. O Donnell, MD, FCCP Bronchodilator therapy in COPD is deemed successful if it improves ventilatory mechanics to
More informationA Primer on Reading Pulmonary Function Tests. Joshua Benditt, M.D.
A Primer on Reading Pulmonary Function Tests Joshua Benditt, M.D. What Are Pulmonary Function Tests Used For? Pulmonary function testing provides a method for objectively assessing the function of the
More informationPredominant emphysema phenotype in chronic obstructive pulmonary disease patients
Eur Respir J 2003; 21: 450 454 DOI: 10.1183/09031936.03.00048703 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2003 European Respiratory Journal ISSN 0903-1936 Predominant phenotype in
More informationOutline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications?
Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications? Fernando Holguin MD MPH Director, Asthma Clinical & Research Program Center for lungs and Breathing University of Colorado
More informationSupramaximal flow in asthmatic patients
Eur Respir J ; 19: 13 17 DOI: 1.113/93193..51 Printed in UK all rights reserved Copyright #ERS Journals Ltd European Respiratory Journal ISSN 93-193 Supramaximal flow in asthmatic patients H. Sala*, A.
More informationDiagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma
ORIGINAL RESEARCH Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma Daphne C Richter 1 James R Joubert 1 Haylene Nell
More informationGender Differences in the Severity of CT Emphysema in COPD*
Original Research COPD Gender Differences in the Severity of CT Emphysema in COPD* Mark T. Dransfield, MD; George R. Washko, MD; Marilyn G. Foreman, MD, FCCP; Raul San Jose Estepar, PhD; John Reilly, MD,
More informationThe role of lung function testing in the assessment of and treatment of: AIRWAYS DISEASE
The role of lung function testing in the assessment of and treatment of: AIRWAYS DISEASE RHYS JEFFERIES ARTP education Learning Objectives Examine the clinical features of airways disease to distinguish
More informationRESPIRATORY PHYSIOLOGY Pre-Lab Guide
RESPIRATORY PHYSIOLOGY Pre-Lab Guide NOTE: A very useful Study Guide! This Pre-lab guide takes you through the important concepts that where discussed in the lab videos. There will be some conceptual questions
More informationClinical Study Bronchial Responsiveness in Patients with Restrictive Spirometry
BioMed Research International Volume 2013, Article ID 498205, 5 pages http://dx.doi.org/10.1155/2013/498205 Clinical Study Bronchial Responsiveness in Patients with Restrictive Spirometry Jean I. Keddissi,
More informationChapter 3. Pulmonary Function Study Assessments. Mosby items and derived items 2011, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Chapter 3 Pulmonary Function Study Assessments 1 Introduction Pulmonary function studies are used to: Evaluate pulmonary causes of dyspnea Differentiate between obstructive and restrictive pulmonary disorders
More informationC hronic obstructive pulmonary disease (COPD) is a
288 CHRONIC OBSTRUCTIVE PULMONARY DISEASE Altered thoracic gas compression contributes to improvement in spirometry with lung volume reduction surgery A Sharafkhaneh, S Goodnight-White, T M Officer, J
More informationSpirometry: an essential clinical measurement
Shortness of breath THEME Spirometry: an essential clinical measurement BACKGROUND Respiratory disease is common and amenable to early detection and management in the primary care setting. Spirometric
More informationPULMONARY FUNCTION TESTS
Chapter 4 PULMONARY FUNCTION TESTS M.G.Rajanandh, Department of Pharmacy Practice, SRM College of Pharmacy, SRM University. OBJECTIVES Review basic pulmonary anatomy and physiology. Understand the reasons
More informationIncreased difference between slow and forced vital capacity is associated with reduced exercise tolerance in COPD patients
Yuan et al. BMC Pulmonary Medicine 2014, 14:16 RESEARCH ARTICLE Open Access Increased difference between slow and forced vital capacity is associated with reduced exercise tolerance in COPD patients Wei
More informationPulmonary Function Testing. Ramez Sunna MD, FCCP
Pulmonary Function Testing Ramez Sunna MD, FCCP Lecture Overview General Introduction Indications and Uses Technical aspects Interpretation Patterns of Abnormalities When to perform a PFT 1. Evaluation
More informationContent Indica c tion Lung v olumes e & Lung Indica c tions i n c paci c ties
Spirometry Content Indication Indications in occupational medicine Contraindications Confounding factors Complications Type of spirometer Lung volumes & Lung capacities Spirometric values Hygiene &
More informationTORCH: Salmeterol and Fluticasone Propionate and Survival in COPD
TORCH: and Propionate and Survival in COPD April 19, 2007 Justin Lee Pharmacy Resident University Health Network Outline Overview of COPD Pathophysiology Pharmacological Treatment Overview of the TORCH
More informationFEVI before (5% predicted) 62 (49-77) 59 (44-77) FEV, after (% predicted) 92 (84-108) 89 (69-107) to the entire group received aerosol isoprenaline.
Tl.orax, 1980, 35, 298-302 Lung elastic recoil and reduced airflow in clinically stable asthma D S McCARTHY AND M SIGURDSON From the Department of Medicine, University ofmanitoba, Respiratory Division,
More informationRespiratory System Mechanics
M56_MARI0000_00_SE_EX07.qxd 8/22/11 3:02 PM Page 389 7 E X E R C I S E Respiratory System Mechanics Advance Preparation/Comments 1. Demonstrate the mechanics of the lungs during respiration if a bell jar
More informationAPSR RESPIRATORY UPDATES
APSR RESPIRATORY UPDATES Volume 4, Issue 7 Newsletter Date: July 2012 APSR EDUCATION PUBLICATION Inside this issue: Quantitative imaging of airways Small-Airway Obstruction and Emphysema in Chronic Obstructive
More informationPatient selection for lung volume reduction surgery. Patient Selection for Lung Volume Reduction Surgery*
Patient Selection for Lung Volume Reduction Surgery* An Objective Model Based on Prior Clinical Decisions and Quantitative CT Analysis David S. Gierada, MD; Roger D. Yusen, MD; Ian A. Villanueva, BS; Thomas
More informationCIRCULAR INSTRUCTION REGARDING ESTABLISHMENT OF IMPAIRMENT DUE TO OCCUPATIONAL LUNG DISEASE FOR THE PURPOSES OF AWARDING PERMANENT DISABLEMENT
Circular Instruction 195 CIRCULAR INSTRUCTION REGARDING ESTABLISHMENT OF IMPAIRMENT DUE TO OCCUPATIONAL LUNG DISEASE FOR THE PURPOSES OF AWARDING PERMANENT DISABLEMENT COMPENSATION FOR OCCUPATIONAL INJURIES
More informationChapter. Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension
Chapter 7 Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension P. Trip B. Girerd H.J. Bogaard F.S. de Man A. Boonstra G. Garcia M. Humbert D. Montani A. Vonk Noordegraaf Eur Respir
More informationبسم هللا الرحمن الرحيم
بسم هللا الرحمن الرحيم Yesterday we spoke of the increased airway resistance and its two examples: 1) emphysema, where we have destruction of the alveolar wall and thus reducing the area available for
More informationComputed Tomography-Based Centrilobular Emphysema Subtypes Relate with Pulmonary Function
Send Orders of Reprints at reprints@benthamscience.net 54 The Open Respiratory Medicine Journal, 213, 7, 54-59 Computed Tomography-Based Centrilobular Emphysema s Relate with Pulmonary Function Mamoru
More informationThe structural basis of airways hyperresponsiveness in asthma
J Appl Physiol 101: 30 39, 2006. First published February 9, 2006; doi:10.1152/japplphysiol.01190.2005. The structural basis of airways hyperresponsiveness in asthma Robert H. Brown, 1,2,3 David B. Pearse,
More informationClinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene
Clinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene Emily S. Wan, John E. Hokanson, James R. Murphy, Elizabeth A. Regan, Barry J. Make, David A. Lynch, James D. Crapo, Edwin K.
More informationAnyone who smokes and/or has shortness of breath and sputum production could have COPD
COPD DIAGNOSIS AND MANAGEMENT CHECKLIST Anyone who smokes and/or has shortness of breath and sputum production could have COPD Confirm Diagnosis Presence and history of symptoms: Shortness of breath Cough
More informationQuantitative assessment of emphysema distribution in smokers and patients with a 1 -antitrypsin deficiency
Respiratory Medicine (2006) 100, 94 100 Quantitative assessment of emphysema distribution in smokers and patients with a 1 -antitrypsin deficiency Trine Stavngaard, Saher B. Shaker, Asger Dirksen Department
More informationFunctional Impairment in Emphysema: Contribution of Airway Abnormalities and Distribution of Parenchymal Disease
Functional Impairment in Emphysema Chest Imaging Original Research Zelena A. Aziz 1 Athol U. Wells 2 Sujal R. Desai 3 Stephen M. Ellis 4 Amanda E. Walker 5 Sharyn MacDonald 6 David M. Hansell 1 Aziz ZA,
More informationRespiratory Disease. Dr Amal Damrah consultant Neonatologist and Paediatrician
Respiratory Disease Dr Amal Damrah consultant Neonatologist and Paediatrician Signs and Symptoms of Respiratory Diseases Cardinal Symptoms Cough Sputum Hemoptysis Dyspnea Wheezes Chest pain Signs and Symptoms
More informationE. Senéterre*, F. Paganin**, J.M. Bruel*, F.B. Michel**, J. Bousquet**
Eur Respir J, 1994, 7, 596 6 DOI: 1.1183/931936.94.73596 Printed in UK - all rights reserved Copyright ERS Journals Ltd European Respiratory Journal ISSN 93-1936 TECHNICAL NOTE Measurement of the internal
More informationUnderstanding the Basics of Spirometry It s not just about yelling blow
Understanding the Basics of Spirometry It s not just about yelling blow Carl D. Mottram, RRT RPFT FAARC Technical Director - Pulmonary Function Labs and Rehabilitation Associate Professor of Medicine -
More informationThis is a cross-sectional analysis of the National Health and Nutrition Examination
SUPPLEMENTAL METHODS Study Design and Setting This is a cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES) data 2007-2008, 2009-2010, and 2011-2012. The NHANES is
More informationNormal Range of Emphysema and Air Trapping on CT in Young Men
Cardiopulmonary Imaging Original Research Mets et al. CT of Emphysema and Air Trapping Cardiopulmonary Imaging Original Research Onno M. Mets 1 Robert A. van Hulst 2,3 Colin Jacobs 4,5 Bram van Ginneken
More informationIs there any correlation between the ATS, BTS, ERS and GOLD COPD s severity scales and the frequency of hospital admissions?
Respiratory Medicine (2004) 98, 178 183 Is there any correlation between the ATS, BTS, ERS and GOLD COPD s severity scales and the frequency of hospital admissions? Maria Tsoumakidou, Nikolaos Tzanakis,
More informationPhysiology lab (RS) First : Spirometry. ** Objectives :-
Physiology lab (RS) ** Objectives :- 1. Spirometry in general. 2. Spirogram (volumes and capacities). 3. The importance of vital capacity in diagnosis. 4. Flow volume loop. 5. Miss Arwa s part (the practical
More informationChapter 11. Summary and general discussion
Chapter 11 Summary and general discussion Low Dose Computed Tomography of the Chest: Applications and Limitations INTRODUCTION The introduction of spiral, multidetector-row computed tomography (CT) has
More informationEffect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients
Eur Respir J 1998; 12: 799 84 DOI: 1.1183/931936.98.124799 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1998 European Respiratory Journal ISSN 93-1936 Effect of salbutamol on dynamic
More informationASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss?
ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss? Randall W. Brown, MD MPH AE-C Association of Asthma Educators Annual Conference July 20, 2018 Phoenix, Arizona FACULTY/DISCLOSURES Randall Brown,
More informationDeep inspiration-induced changes in lung volume decrease with severity of asthma $
Respiratory Medicine (2007) 101, 951 956 Deep inspiration-induced changes in lung volume decrease with severity of asthma $ Nicola Scichilone a,, Roberto Marchese a, Simona Soresi a, Amelia Interrante
More informationChronic Obstructive Pulmonary Disease (COPD) Clinical Guideline
Chronic Obstructive Pulmonary Disease (COPD) Clinical These clinical guidelines are designed to assist clinicians by providing an analytical framework for the evaluation and treatment of patients. They
More informationStudy No.: Title: Rationale: Phase: Study Period Study Design: Centres: Indication: Treatment: Objectives : Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationRelationship between the Severity of Airway Obstruction and Inspiratory Muscles Dysfunction in COPD Patients
ORIGINAL ARTICLE Tanaffos (2009) 8(3), 37-42 2009 NRITLD, National Research Institute of Tuberculosis and Lung Disease, Iran Relationship between the Severity of Airway Obstruction and Inspiratory Muscles
More informationAbnormalities of plethysmographic lung volumes in asthmatic children
Respiratory Medicine (2010) 104, 966e971 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed Abnormalities of plethysmographic lung volumes in asthmatic children Bruno Mahut
More informationCopyright 2008 Society of Photo Optical Instrumentation Engineers. This paper was published in Proceedings of SPIE, vol. 6915, Medical Imaging 2008:
Copyright 2008 Society of Photo Optical Instrumentation Engineers. This paper was published in Proceedings of SPIE, vol. 6915, Medical Imaging 2008: Computer Aided Diagnosis and is made available as an
More informationThe Aging Lung. Sidney S. Braman MD FACP FCCP Professor of Medicine Brown University Providence RI
The Aging Lung Sidney S. Braman MD FACP FCCP Professor of Medicine Brown University Providence RI Is the respiratory system of the elderly different when compared to younger age groups? Respiratory Changes
More informationDependence of forced vital capacity manoeuvre on time course of preceding inspiration in patients with restrictive lung disease
Eur Respir J 1997; 1: 2366 237 DOI: 1.1183/931936.97.112366 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1997 European Respiratory Journal ISSN 93-1936 Dependence of forced vital capacity
More informationContribution of Emphysema and Small Airways in COPD*
Contribution of Emphysema and Small Airways in COPD* Arthur F. Gelb, MD, FCCP; James C. Hogg, MD; Nestor L. Miiller, MD, PhD, FCCP; Mark]. Schein, MD; Joseph Kuei, MD, FCCP; Donald P. Tashkin, MD, FCCP;
More informationAsma, BPCO ed Esercizio Fisico Ferrara, 6 e 7 Novembre Overlap asma BPCO. Dr. Marco Contoli
Asma, BPCO ed Esercizio Fisico Ferrara, 6 e 7 Novembre 2015 Overlap asma BPCO Dr. Marco Contoli Sezione di Medicina Interna e Cardio-Respiratoria Dipartimento di Scienze Mediche Università di Ferrara (Sept.
More informationKnown Allergies: Shellfish. Symptoms: abdominal pain, nausea, diarrhea, or vomiting. congestion, trouble breathing, or wheezing.
CSTAR CASE STUDIES: BLOCK B Asthma or COPD? Setting: Walk in clinic. Dan: I havi g that cough thi g agai HPI: Dan is a 49-year-old male teacher who reports having had episodes of cough with mucus production
More informationResponses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype *
Respiratory Medicine (2010) 104, 542e549 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed Responses to inhaled long-acting beta-agonist and corticosteroid according to
More informationObjectives. Pulmonary Assessment 12/13/2017
Pulmonary Assessment Reid Blackwelder, MD, FAAFP Professor and Chair, Family Medicine Quillen Colege of Medicine, ETSU Objectives Understand anatomy and physiology of pulmonary assessment techniques Remember
More informationPULMONARY FUNCTION TEST(PFT)
PULMONARY FUNCTION TEST(PFT) Objectives: By the end of the present lab, students should be able to: 1. Record lung volumes and capacities and compare them with those of a typical person of the same gender,
More informationPulmonary Function Testing
Pulmonary Function Testing Let s catch our breath Eddie Needham, MD, FAAFP Program Director Emory Family Medicine Residency Program Learning Objectives The Astute Learner will: Become familiar with indications
More informationLecture Notes. Chapter 4: Chronic Obstructive Pulmonary Disease (COPD)
Lecture Notes Chapter 4: Chronic Obstructive Pulmonary Disease (COPD) Objectives Define COPD Estimate incidence of COPD in the US Define factors associated with onset of COPD Describe the clinical features
More informationDifferential diagnosis
Differential diagnosis The onset of COPD is insidious. Pathological changes may begin years before symptoms appear. The major differential diagnosis is asthma, and in some cases, a clear distinction between
More informationCOPD. Information is arranged in a way to make it easy to understand.
COPD The sheet is divided into : 1- Some types of COPD 2- Tests for diagnosis of COPD Information is arranged in a way to make it easy to understand. First part: COPDs The term means Chronic Obstructive
More informationClinical pulmonary physiology. How to report lung function tests
Clinical pulmonary physiology or How to report lung function tests Lung function testing A brief history Why measure? What can you measure? Interpretation/ reporting Examples and case histories Exercise
More informationBronchoconstriction in Response to Deep Inhalation During Spirometry Testing
Bronchoconstriction in Response to Deep Inhalation During Spirometry Testing Jeffrey M Haynes RRT RPFT Introduction In healthy individuals, airway resistance has an inverse relationship with lung volume.
More informationPulmonary Function Tests. Mohammad Babai M.D Occupational Medicine Specialist
Pulmonary Function Tests Mohammad Babai M.D Occupational Medicine Specialist www.drbabai.com Pulmonary Function Tests Pulmonary Function Tests: Spirometry Peak-Flow metry Bronchoprovocation Tests Body
More informationResistance-Volume Chart (R-V Chart) for simplified clinical and visual interpretation of body plethysmography
Resistance-Volume Chart (R-V Chart) for simplified clinical and visual interpretation of body plethysmography Hans-Jürgen Smith CareFusion, Höchberg Resistance-Volume Chart Innovation in bodyplethysmography
More informationWhat lung function data are relevant concerning the assessment of COPD patients for out patient rehabilitation?
What lung function data are relevant concerning the assessment of COPD patients for out patient rehabilitation? An information package on lung function tests and interpretation of test data in identifying
More informationS P I R O M E T R Y. Objectives. Objectives 3/12/2018
S P I R O M E T R Y Dewey Hahlbohm, PA-C, AE-C Objectives To understand the uses and importance of spirometry testing To perform spirometry testing including reversibility testing To identify normal and
More informationKerstin Cederlund, MD, PhD; Ulf Tylén, MD, PhD; Lennart Jorfeldt, MD, PhD; and Peter Aspelin, MD, PhD
Classification of Emphysema in Candidates for Lung Volume Reduction Surgery* A New Objective and Surgically Oriented Model for Describing CT Severity and Heterogeneity Kerstin Cederlund, MD, PhD; Ulf Tylén,
More information